- Home
- PTCT vs HTGC Comparison
PTCT vs HTGC Comparison
Compare PTCT & HTGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PTCT | HTGC |
|---|---|---|
| Founded | 1998 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 3.2B |
| IPO Year | 2013 | 2005 |
Fundamental Metrics
Financial Performance| Metric | PTCT | HTGC |
|---|---|---|
| Price | $77.48 | $19.01 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 8 |
| Target Price | ★ $73.76 | $21.13 |
| AVG Volume (30 Days) | ★ 2.3M | 1.3M |
| Earning Date | 11-04-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 9.91% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 8.94 | 1.75 |
| Revenue | ★ $1,779,150,000.00 | $516,847,000.00 |
| Revenue This Year | $128.32 | $8.72 |
| Revenue Next Year | N/A | $9.57 |
| P/E Ratio | ★ $8.64 | $10.83 |
| Revenue Growth | ★ 97.54 | 4.54 |
| 52 Week Low | $35.95 | $15.65 |
| 52 Week High | $87.50 | $22.04 |
Technical Indicators
Market Signals| Indicator | PTCT | HTGC |
|---|---|---|
| Relative Strength Index (RSI) | 54.29 | 71.21 |
| Support Level | $73.03 | $17.86 |
| Resistance Level | $79.03 | $17.67 |
| Average True Range (ATR) | 3.38 | 0.30 |
| MACD | -0.70 | 0.18 |
| Stochastic Oscillator | 29.37 | 94.21 |
Price Performance
Historical ComparisonAbout PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
About HTGC Hercules Capital Inc.
Hercules Capital Inc is a specialty finance company that provides senior secured loans to high-growth, venture capital-backed companies in various technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries, including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.